Literature DB >> 23329207

Predictors for recurrent primary intracerebral hemorrhage: a retrospective population-based study.

Juha Huhtakangas1, Pekka Löppönen, Sami Tetri, Seppo Juvela, Pertti Saloheimo, Michaela K Bode, Matti Hillbom.   

Abstract

BACKGROUND AND
PURPOSE: Underlying comorbidities, previous strokes, and medication may increase the risk for primary intracerebral hemorrhage (PICH) and its recurrence. The aim of this study was to determine the independent predictors for recurrent PICH.
METHODS: We identified 961 subjects with first-ever PICH from 1993 to 2008 among the population of Northern Ostrobothnia, Finland. Hospital and death records were reviewed and data on drug use were obtained from the national register of prescribed medicines. Kaplan-Meier survival curves and Cox proportional hazards models were used to demonstrate predictors for recurrence of PICH.
RESULTS: Total follow-up time of the 961 patients was 3481 person-years. During the follow-up time, 58 subjects had altogether 68 recurrent PICHs. The annual average incidence of first recurrence was 1.67%. Cumulative 5- and 10-year incidence rates were 9.6% and 14.2%, respectively. In univariable analysis, history of ischemic stroke, diabetes mellitus, and aspirin use were associated with a higher recurrence rate. In multivariable analysis, only previous ischemic stroke (adjusted hazard ratio, 2.22; 95% confidence interval, 1.22-4.05; P=0.009) independently predicted PICH recurrence. Diabetes mellitus tended to increase (adjusted hazard ratio, 2.38; 95% confidence interval, 0.98-5.80; P=0.056), whereas treated hypertension tended to decrease (0.45, 0.20-1.01; P=0.054) the risk for fatal recurrent PICH.
CONCLUSIONS: Previous ischemic stroke independent of confounding factors may increase the risk for PICH recurrence.

Entities:  

Mesh:

Year:  2013        PMID: 23329207     DOI: 10.1161/STROKEAHA.112.671230

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings.

Authors:  Aaron L Berkowitz; M Brandon Westover; Matt T Bianchi; Sherry H-Y Chou
Journal:  Neurology       Date:  2014-08-13       Impact factor: 9.910

2.  Aspirin and intracerebral hemorrhage: Where are we now?

Authors:  Réza Behrouz; Chad M Miller
Journal:  Neurol Clin Pract       Date:  2015-02

3.  Clinical characteristics and outcome of intracerebral hemorrhage in young adults.

Authors:  Loes Ca Rutten-Jacobs; Noortje Am Maaijwee; Renate M Arntz; Hennie C Schoonderwaldt; Lucille D Dorresteijn; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  J Neurol       Date:  2014-08-20       Impact factor: 4.849

Review 4.  In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation.

Authors:  Teng J Peng; Catherine Viscoli; Pooja Khatri; Stacey Q Wolfe; Nirav R Bhatt; Tarun Girotra; Hooman Kamel; Kevin N Sheth
Journal:  Drugs       Date:  2022-06-03       Impact factor: 11.431

Review 5.  Cardiovascular Events After Intracerebral Hemorrhage.

Authors:  Linxin Li; Santosh B Murthy
Journal:  Stroke       Date:  2022-06-08       Impact factor: 10.170

6.  Lobar intracerebral hemorrhage and risk of subsequent uncontrolled blood pressure.

Authors:  Evangelos Pavlos Myserlis; Ernst Mayerhofer; Jessica R Abramson; Kay-Cheong Teo; Bailey E Montgomery; Lansing Sugita; Andrew D Warren; Joshua N Goldstein; Mahmut Edip Gurol; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Christopher D Anderson; Jonathan Rosand
Journal:  Eur Stroke J       Date:  2022-04-27

7.  The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis.

Authors:  Melanie P Jensen; Oliver J Ziff; Gargi Banerjee; Gareth Ambler; David J Werring
Journal:  Eur Stroke J       Date:  2019-01-25

8.  Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects.

Authors:  Linnea Boegeskov Schmidt; Sanne Goertz; Jan Wohlfahrt; Mads Melbye; Tina Noergaard Munch
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

9.  Racial/ethnic disparities in the risk of intracerebral hemorrhage recurrence.

Authors:  Audrey C Leasure; Zachary A King; Victor Torres-Lopez; Santosh B Murthy; Hooman Kamel; Ashkan Shoamanesh; Rustam Al-Shahi Salman; Jonathan Rosand; Wendy C Ziai; Daniel F Hanley; Daniel Woo; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth
Journal:  Neurology       Date:  2019-12-12       Impact factor: 11.800

Review 10.  Management of acute stroke in patients taking novel oral anticoagulants.

Authors:  Graeme J Hankey; Bo Norrving; Werner Hacke; Thorsten Steiner
Journal:  Int J Stroke       Date:  2014-06-02       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.